Astrid Zimmermann
14Patents
2h-index
44Co-inventors
50Inventor score
Filing activity: Mar 14, 2006 → Sep 26, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7666868B2 | N-sulphonylpyrroles and their use as histone deacetylase inhibitors | Chemistry; Metallurgy | 12 | Expired |
| US9908880B2 | Substituted imidazoquinolines | Emerging Cross-Sectional Technologies | 2 | Active |
| US9073913B2 | Substituted imidazoquinolines | Emerging Cross-Sectional Technologies | 2 | Active |
| US8592591B2 | Fused bicyclic imidazoles | Chemistry; Metallurgy | 2 | Active |
| US8440830B2 | Tetrahydro-fused pyridines as histone deacetylase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9446040B2 | Substituted imidazoquinolines | Emerging Cross-Sectional Technologies | 1 | Active |
| US7776864B2 | Fused bicyclic pyrimidines | Human Necessities | 1 | Active |
| US8273890B2 | Thiophene-imidazopyridines | Human Necessities | 0 | Active |
| US8614218B2 | Fused bicyclic pyrimidines | Human Necessities | 0 | Active |
| US12227577B2 | Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for the treatment of cancer | Physics | 0 | Active |
| US11246929B2 | Combination of a protein kinase inhibitor and an additional chemotherapeutic agent | Human Necessities | 0 | Active |
| US9387204B2 | Fused bicyclic imidazoles | Chemistry; Metallurgy | 0 | Active |
| US8530493B2 | Indolopyridines as Eg5 kinesin modulators | Human Necessities | 0 | Active |
| US8815855B2 | N-sulphonylpyrroles and their use as histone deacetylase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.